Identify and Evaluate Manufacturer-Level Drug Utilization and Switching Patterns in Sentinel

Project Title Identify and Evaluate Manufacturer-Level Drug Utilization and Switching Patterns in Sentinel
Description

The Office of Generic Drugs (OGD) at the Center for Drug Evaluation and Research (CDER) is interested in exploring the potential for the Sentinel System to support investigations of manufacturer-level product switching. The aims of this project are: 

  1. Design, develop, test and evaluate a flexible and reusable prototype analytic tool that could be used to conduct rapid population-based assessments on new generic products in the future; and
  2. Use the Sentinel System to characterize utilization and switching patterns associated with two use-cases: Toprol XL (metoprolol ER) and Lamictal XR (lamotrigine ER). 
Link
Published Date
Monday, December 12, 2016
Category
Study Protocols and Surveillance Plans